Meta-analysis Nutrients · 2026 Efficacy and Safety of Lactobacillus reuteri DSM 17938 in Pediatric Functional Abdominal Pain Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Rodríguez-Brown F, Guerra Valencia J, Hernández-Vásquez A Limosilactobacillus reuteri PubMed ↗
Randomized trial Nutrients · 2026 Long-Term Efficacy of Limosilactobacillus reuteri DSM17938 in the Prevention of Functional Abdominal Pain Disorders. Indrio F, Di Mauro A, Perrone G, et al. Limosilactobacillus reuteri PubMed ↗
Randomized trial Beneficial microbes · 2026 Effects of a Bacillus subtilis HU58 and Heyndrickxia faecalis SC208 spore-forming probiotic formula on gastrointestinal health: results of a randomised, double-blind, placebo-controlled pilot study. Sorensen K, Khanna S, Porwal A, et al. Bacillus subtilisHeyndrickxia coagulans PubMed ↗
Randomized trial Journal of gastroenterology and hepatology · 2025 Effect of Probiotics on the Gut Microbiota After Colonoscopy: A Multicenter, Randomized, Placebo-Controlled Clinical Study. Wei H, Wang J, Xiao X, et al. Bacillus subtilisEnterococcus faeciumBacteroides PubMed ↗
Randomized trial The American journal of gastroenterology · 2025 Efficacy and Safety of Gelatin Tannate and Tyndallized Acid Lactic Bacteria in Adults With Chronic Diarrhea and Altered Gut Microbiota: A Randomized, Double-Blind, Placebo-Controlled Study. Santos J, Iordache A, Manolache M Akkermansia muciniphilaFaecalibacterium prausnitzii PubMed ↗
Observational Nutrients · 2025 Management of Post-Colonoscopy Syndrome with a Nutraceutical Intervention Based on Hericium erinaceus: A Retrospective Two-Arm Multicentre Analysis. Tursi A, D'Avino A, Brandimarte G, et al. Bifidobacterium animalisLactobacillus acidophilus PubMed ↗
Randomized trial Beneficial microbes · 2025 Effects of spore-forming probiotic Bacillus subtilis HU58™ in children with antibiotic-associated diarrhoea: a randomised, double-blind, placebo-controlled trial. Sorensen K, Jog P, Mankar S, et al. Bacillus subtilis PubMed ↗
Randomized trial Phytomedicine · 2025 Butyrate-producing commensal bacteria mediates the efficacy of herbal medicine JCM-16021 on abdominal pain in diarrhea-predominant irritable bowel syndrome: a randomized clinical trial. Zhai L, Zheng Y, Lo CW, et al. Agathobacter rectalis PubMed ↗
Randomized trial Beneficial microbes · 2024 Oral supplementation of heat-killed Enterococcus faecalis strain EC-12 relieves gastrointestinal discomfort and alters the gut microecology in academically stressed students. Li J, Terajima T, Liu H, et al. Enterococcus faecalis PubMed ↗
Observational World journal of gastroenterology · 2024 Correlation between the neuroendocrine axis, microbial species, inflammatory response, and gastrointestinal symptoms in irritable bowel syndrome. Zhang X, Jin WW, Wang HG Faecalibacterium PubMed ↗
Observational The American journal of gastroenterology · 2024 Fecal Proteolytic Bacteria and Staphylococcal Superantigens Are Associated With Abdominal Pain Severity in Irritable Bowel Syndrome. Quan R, Decraecker L, Appeltans I, et al. Alistipes putredinisFaecalibacterium prausnitziiParaprevotella clara PubMed ↗
Observational Digestive and liver disease · 2024 Differences in clinical manifestations and the fecal microbiome between irritable bowel syndrome and small intestinal bacterial overgrowth. Lu S, Chen Y, Guo H, et al. EscherichiaLachnoclostridium PubMed ↗
Review Endocrinologia, diabetes y nutricion · 2024 Evaluation of the efficacy of probiotics as treatment in irritable bowel syndrome. Ruiz-Sánchez C, Escudero-López B, Fernández-Pachón MS Bifidobacterium bifidum PubMed ↗
Review Nutrients · 2024 Nutraceuticals and Pain Disorders of the Gut-Brain Interaction in Infants and Children: A Narrative Review and Practical Insights. Salvatore S, Carlino M, Sestito S, et al. Bifidobacterium animalisLacticaseibacillus rhamnosusLimosilactobacillus reuteri PubMed ↗
Meta-analysis BMC infectious diseases · 2023 The effect of Saccharomyces boulardii supplementation on Helicobacter pylori eradication in children: a systematic review and meta-analysis of Randomized controlled trials. Liu LH, Han B, Tao J, et al. Saccharomyces cerevisiae PubMed ↗
Systematic review Nutrients · 2023 Outcome-Specific Efficacy of Different Probiotic Strains and Mixtures in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis. Xie P, Luo M, Deng X, et al. Heyndrickxia coagulansLactobacillus acidophilusSaccharomyces cerevisiae PubMed ↗
Randomized trial Helicobacter · 2023 Probiotic containing Lactobacillus reuteri DSM 17648 as an adjunct treatment for Helicobacter pylori infection: A randomized, double-blind, placebo-controlled trial. Ismail NI, Nawawi KNM, Hsin DCC, et al. Limosilactobacillus reuteri PubMed ↗
Review Frontiers in cellular and infection microbiology · 2023 Lactobacillus reuteri in digestive system diseases: focus on clinical trials and mechanisms. Peng Y, Ma Y, Luo Z, et al. Limosilactobacillus reuteri PubMed ↗
Meta-analysis Gastroenterology · 2023 Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysis. Goodoory VC, Khasawneh M, Black CJ, et al. Lactiplantibacillus plantarumBifidobacteriumEscherichia PubMed ↗
Observational BMC gastroenterology · 2023 Eubiotic effect of rifaximin is associated with decreasing abdominal pain in symptomatic uncomplicated diverticular disease: results from an observational cohort study. Ivashkin V, Shifrin O, Maslennikov R, et al. AnaerostipesDialister PubMed ↗